Cargando…
In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
An outbreak caused by 2019 novel coronavirus (2019-nCoV) was first identified in Wuhan City, Hubei Province, China. The new virus was later named SARS-CoV-2. The virus has affected tens of thousands of patients in the world. The infection of SARS-CoV-2 causes severe pneumonia and even death. It is u...
Autores principales: | Ling, Rongsong, Dai, Yarong, Huang, Boxuan, Huang, Wenjie, Yu, Jianfeng, Lu, Xifeng, Jiang, Yizhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198429/ https://www.ncbi.nlm.nih.gov/pubmed/32380200 http://dx.doi.org/10.1016/j.peptides.2020.170328 |
Ejemplares similares
-
Antibody-dependent enhancement of coronavirus
por: Wen, Jieqi, et al.
Publicado: (2020) -
Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options
por: Huang, Boxuan, et al.
Publicado: (2020) -
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
por: Khater, Ibrahim, et al.
Publicado: (2022) -
In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021) -
An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
por: Ho, Chian, et al.
Publicado: (2023)